Described herein are opioid prodrugs, methods of making opioid prodrugs, formulations comprising opioid prodrugs, and methods of using opioid prodrugs. One embodiment described herein relates to the transdermal administration of a buprenorphine prodrug in an abuse-resistant formulation for treating and preventing diseases and/or disorders.

 
Web www.patentalert.com

< Novel Proteasome Modulators

> Phosphorylated Polyphenols as Colour-Stable Agents

~ 00421